# Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome

> **NCT01108068** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 26 (actual)

## Conditions studied

- Osteoporosis Pseudoglioma

## Interventions

- **DRUG:** Lithium

## Key facts

- **NCT ID:** NCT01108068
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108068, "Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01108068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*